Camp4 Therapeutics (NASDAQ:CAMP) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Camp4 Therapeutics (CAMP) operate in?

Camp4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Camp4 Therapeutics Stock (NASDAQ: CAMP) stock price, news, charts, stock research, profile.

Open	$5.20
Close	$5.20
Volume / Avg.	984.32K / 111.62K
Day Range	$4.61 - $6.31
52 Wk Range	0.39 - 153.41
Market Cap	$117.34M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	2.58%
Days to Cover	5.72

Recent News

Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

CAMP4 Analyst Highlights Rare Disease Platform Potential

CAMP4 Therapeutics raises $75 million in IPO, advances RNA therapies for rare diseases, and partners with BioMarin. Analysts project $1 billion in revenue for UCD drug by 2036.

Vandana Singh

Why Contango Ore Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.7

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$5.20
Close	$5.20
Volume / Avg.	984.32K / 111.62K
Day Range	$4.61 - $6.31
52 Wk Range	0.39 - 153.41
Market Cap	$117.34M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	2.58%
Days to Cover	5.72

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Camp4 Therapeutics (CAMP) stock?

You can purchase shares of Camp4 Therapeutics (NASDAQ:CAMP) through any online brokerage.

View our list of the best stock brokerages

Who are Camp4 Therapeutics (CAMP) competitors?

Other companies in Camp4 Therapeutics’s space includes: Cabaletta Bio (NASDAQ:CABA), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS), Tonix Pharmaceuticals (NASDAQ:TNXP) and Lineage Cell Therapeutics (AMEX:LCTX).

What is the forecast, or price target, for Camp4 Therapeutics (CAMP) stock?

Camp4 Therapeutics has a consensus price target of $9.97.

What is the current price for Camp4 Therapeutics (CAMP)?

The stock price for Camp4 Therapeutics (NASDAQ: CAMP) is $5.82 last updated December 20, 2024 at 8:59 AM EST.

Does Camp4 Therapeutics (CAMP) pay a dividend?

There are no upcoming dividends for Camp4 Therapeutics.

When is Camp4 Therapeutics (NASDAQ:CAMP) reporting earnings?

Camp4 Therapeutics’s Q4 earnings are confirmed for Friday, February 14, 2025.

Is Camp4 Therapeutics (CAMP) going to split?

There is no upcoming split for Camp4 Therapeutics.

What sector and industry does Camp4 Therapeutics (CAMP) operate in?

Camp4 Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Camp4 Therapeutics

Camp4 Therapeutics (CAMP) Forecast